Back to Search Start Over

Bluebird Bio lifts voluntary marketing suspension of Zynteglo

Source :
The Fly. July 9, 2021
Publication Year :
2021

Abstract

Bluebird Bio, announced that the European Medicines Agency's, or EMA, Pharmacovigilance Risk Assessment Committee, or PRAC, has concluded based on the review of all available data that the benefit-risk balance [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
The Fly
Publication Type :
Periodical
Accession number :
edsgcl.667956195